Skip to main content
A preview of the late-breaking science at IAS 2025

A preview of the late-breaking science at IAS 2025

We are excited to share some of the late-breaking HIV research that will be presented at IAS 2025, the 13th IAS Conference on HIV Science, in Kigali, Rwanda, and virtually from 13 to 17 July.
 

Impact of funding cuts

Delegates will be presented with compelling new evidence showing how sudden funding cuts are endangering decades of progress in the global HIV response, including:

  • Real-time evidence from Mozambique on how funding cuts have disrupted HIV services and how they could impact HIV incidence and HIV-related mortality until 2030
  • Modelling the projected impact of HIV incidence and mortality in western Africa, and assessing the impact of pre-exposure prophylaxis (PrEP) access on HIV incidence among key populations in central, eastern, southern and western Africa
  • Reports from organizations from 13 countries in the Latin America and the Caribbean region on how funding cuts have impacted the HIV response
     

Long-acting technologies

IAS 2025 will spotlight advances in long-acting injectable options, which could help move us closer to ending the HIV pandemic as a threat to public health and individual well-being. Find out more about:

Check out the full programme to find out more about these and other timely presentations.

Join us 

IAS 2025, the 13th IAS Conference on HIV Science, returns the conference to the African continent, which is at the heart of the HIV response. IAS 2025 will highlight the latest science, innovation and frontline efforts in addressing HIV in Africa and across the globe.

The conference will present a powerful opportunity to come together to inform, engage and inspire urgent global action to chart a new and equitable path forward.

Don't miss out. Be a part and help shape the future of the HIV response. Join thousands of scientists, policy makers and activists in Kigali, Rwanda and virtually, from 13 to 17 July!
 

Register now

 

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.